March 12, 2010
News Categories
Arthritis
Autoimmunity
BioPharm Business
Bones
Consumer News
Imaging
Pain
Procedures
Skin
Spondyloarthropathies
Meeting Highlights
ISEMIR 2009:
Video coverage of the Meeting
Miami, March 27, 2009
Miami, March 27, 2009
RWCS 2009:
Video coverage of the Symposium
Maui, January 14-17, 2009
Maui, January 14-17, 2009
ACR 2008:
News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
San Francisco, October 24-29, 2008
EULAR 2008:
Coverage of the Congress
Paris, June 11-14, 2008
Paris, June 11-14, 2008
ISEMIR 2008:
Video coverage of the Meeting
Chicago, April 10, 2008
Chicago, April 10, 2008
AAOS 2008:
News from the Annual Meeting
San Francisco, March 5-9, 2008
San Francisco, March 5-9, 2008
Affiliations
advertisement
ACR 2006 Video
| Tuesday, November 14, 2006 | |
|---|---|
  |
Decrease in Need for Home Help with improved clinical status in RA Patients –
Tracy Li, PhD, Bristol-Myers Squibb |
 |
Predictors of Five-year Incident Fractures: Results From The National
Osteoporosis Risk Assessment Program (NORA) – Ethel S. Siris, MD, Columbia University |
 |
Efficacy of Traditional Chinese Acupuncture in the Treatment of Rheumatoid
Arthritis (RA): A Double-Blind Controlled Pilot Study - again, ways to help
symptoms without medication – Lai-Shan Tam, MD, Chinese University of Hong Kong |
 |
A Six-month, Double-blind, Placebo-controlled, Durability of Effect Study of
Pregabalin for Pain Associated With Fibromyalgia – Leslie J. Crofford, MD, University of Kentucky |
 |
High Humidity and High Temperature Increase the Risk of Recurrent Gout
Attacks: The Online Case-crossover Gout Study – Yuqing Zhang, DSc, Boston University |
 |
Serum Matrix Metalloproteinase 3 is an Independent Predictor of Structural
Damage Progression in Patients with Ankylosing Spondylitis – Walter P. Maksymowych, MD, University of Alberta |
 |
The Association of New Cases of Cancer with Biologic Therapy – Frederick Wolfe, MD, National Data Bank for Rheumatic Diseases |
 |
The Response To TNF-alpha Blockade In Rheumatoid Arthritis Is In Part
Dependent On TNF-alpha Expression In The Synovium – Paul P. Tak, MD, Academic Medical Center/University of Amsterdam |
 |
Abilities to Develop Protective Antibodies to Pneumococcal and Influenza
Vaccine Are Maintained in RA Patients Treated with Adalimumab (Humira) –
(Kivitz) speaking on behalf of Jeffrey Kaine, MD, Sarasota Arthritis Center |
 |
National Study of Medical Complications in SLE Pregnancies – Megan E. Clowse, MD, MPH, Duke University Medical Center |
| Monday, November 13, 2006 | |
|---|---|
 |
Quadriceps Strength and Its Relation to Cartilage Loss in Knee Osteoarthritis–
Shreyasee Amin, Mayo Clinic |
 |
Evidence for Reciprocal Relationships Among Pain, Weight Loss and Long Term
Weight Maintenance for Obese Persons with Knee OA – Steffany Haaz, Johns Hopkins University |
 |
Interim Report of a Randomized Double Blind Controlled Trial of Intra-articular
Botulinum Toxin Type A (IA-BoNT/A) vs Placebo for Moderate and Severe
Refractory Knee Pain due to Osteoarthritis – Maren Mahowald, MD, Minneapolis VA Medical Center |
 |
The Lifetime Risk of Symptomatic Hip OA is One in Four – Louise Murphy, PhD, Centers for Disease Control and Prevention |
 |
Autologous Non-myeloablative Peripheral Blood Stem Cell Transplantation in
Patients with Systemic Sclerosis -shows there is hope for this disease – Walter G. Barr, MD, Northwestern University |
 |
Evidence for a Window of Opportunity in a Double-blind Randomized Clinical
Trial in Patients with Undifferentiated Arthritis: The Probable Rheumatoid
Arthritis: Methotrexate Versus Placebo Treatment (the Prompt) study – Tom W.J. Huizinga, MD, Leiden University Medical Center |
 |
Long-Term Efficacy and Safety of Adalimumab in Children with Juvenile
Rheumatoid Arthritis: 48-Week Results – Daniel J. Lovell, MD, MPH, Children’s Hospital Medical Center |
 |
Remission Induction in Early RA with Initial Infliximab and Methotrexate
Therapy: The Disease Course After IFX Discontinuation in the BeSt Trial – CF Allaart, MD, Leiden University Medical Center, Leiden, The Netherlands |
 |
Rapid Improvement of Signs and Symptoms Associated with Systemic
286 Juvenile Idiopathic Arthritis by Interleukin-6 Blockade- Results from a
tocilizumab sJIA Phase III clinical trial and Efficacy and Safety of tocilizumab,
an Anti-IL-6 Receptor Monoclonal Antibody, in Patients with Polyarticular or
Oligoarticular Onset Juvenile Idiopathic Arthritis – Shumpei Yokota, MD, Department of Pediatrics, Yokohama City University School of Medicine |
The videos require the Flash player to view, download and install the Flash Player.
News Categories:
Arthritis |
Autoimmunity |
BioPharm Business |
Bones |
Imaging |
Procedures |
Skin |
Spondyloarthropathies
Events:
ACR 2007 |
ASBMR 2007 |
EULAR 2007 |
GARN 2007 |
LUPUS 2007 |
EULAR 2006 |
ACR 2006 |
ORS 2006 |
OARSI 2006
CME:
Publications:
About Us:
